- Home
- ANY vs VTGN Comparison
ANY vs VTGN Comparison
Compare ANY & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.54
Company Overview
Basic Information| Metric | ANY | VTGN |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | United States |
| Employees | 4 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.9M | 24.1M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ANY | VTGN |
|---|---|---|
| Price | $4.04 | $0.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $30.00 | $0.90 |
| AVG Volume (30 Days) | ★ 5.7M | 717.7K |
| Earning Date | 05-05-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,181,000.00 | N/A |
| Revenue This Year | $15.62 | $124.49 |
| Revenue Next Year | N/A | $353.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.16 | $0.43 |
| 52 Week High | $6.20 | $5.14 |
Technical Indicators
Market Signals| Indicator | ANY | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 63.62 | 37.69 |
| Support Level | $0.74 | $0.54 |
| Resistance Level | N/A | $0.67 |
| Average True Range (ATR) | 0.65 | 0.05 |
| MACD | 0.27 | -0.01 |
| Stochastic Oscillator | 54.35 | 1.55 |
Price Performance
Historical Comparison ANY
VTGN
About ANY Sphere 3D Corp.
Sphere 3D Corp is engaged in the Bitcoin mining business. The company has established an enterprise-scale mining operation through the procurement of mining equipment and partnering with experienced service providers. It generates revenue from mining and selling Bitcoin.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.